Navigating One’s Bio-Pharma Career through 2023’s Turbulent Job Markets
Pharmaceutical Commerce
FEBRUARY 3, 2023
Jasmin Patel of a-Connect provides insight on how to navigate the ebbs and flows of employment.
Sat.Jan 28, 2023 - Fri.Feb 03, 2023
52 
J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries
Fierce Pharma
FEBRUARY 3, 2023
J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries mbayer Fri, 02/03/2023 - 09:29
GoodRx Illegally Sold Users’ Data to Google & Facebook, FTC Says
MedCity News
FEBRUARY 1, 2023
GoodRx failed to notify users that it sold their personal health information to Google, Facebook and other tech companies, the FTC claimed. The agency filed an order that prohibits GoodRx from sharing its users’ data with third parties for advertising purposes and requires the company to pay a $1.5 million penalty. GoodRx agreed to pay the settlement but did not admit to wrongdoing.
How pharma can differentiate the customer experience (CX) it provides to HCPs
Dominic Tyer
JANUARY 28, 2023
DT’s first global customer experience (CX) benchmark is based on a survey of 6,270 HCPs across 14 markets and 8 specialty areas
AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
HIV vaccines suffer setbacks but new approaches could turn the tide
Pharmaceutical Technology
FEBRUARY 3, 2023
Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections. This marks the second time one of Janssen’s HIV vaccines failed after another showed disappointing results in the Phase IIb Imbokodo trial in August 2021.
Pfizer warns Comirnaty sales will plummet by nearly two-thirds in 2023. And Paxlovid won't fare much better
Fierce Pharma
JANUARY 31, 2023
Pfizer warns Comirnaty sales will plummet by nearly two-thirds in 2023.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
This biotech CEO secured two billion-dollar Big Pharma deals during the pandemic
PharmaVoice
JANUARY 31, 2023
With the industry focused on cancer and COVID-19, Marc de Garidel made deals centered on cardio.
Halting Europe’s essential medicines manufacturing exodus
European Pharmaceutical Review
FEBRUARY 2, 2023
While maintaining a healthy manufacturing industry for production of ‘high tech’ pharmaceuticals, Europe has stepped away from manufacturing essential medicines and active pharmaceutical ingredients (APIs) due to unrelenting price pressures and is now heavily reliant on the import of these critical ingredients. There is now a large regional concentration in the production of generic APIs in Asia with 66 percent of the world’s API production by volume manufactured in India and China. 1 Europe is
In mysterious FDA approval, Pfizer quietly wins Ibrance breast cancer expansion
Fierce Pharma
JANUARY 31, 2023
In mysterious FDA approval, Pfizer quietly wins Ibrance breast cancer expansion aliu Tue, 01/31/2023 - 10:37
FDA Asks Gene Therapy Biotech to Run Clinical Trial That Might Be Impossible
MedCity News
FEBRUARY 1, 2023
Taysha Gene Therapies has encouraging data from an open-label, Phase 1/2 study in the rare disease giant axonal neuropathy. It might not be enough. The FDA recommended the biotech conduct a randomized and placebo-controlled study—a challenge in any ultra-rare disease.
5 Ways You Can Win Faster with Gen AI in Sales
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
uniQure signs license deal for Apic Bio’s gene therapy for SOD1-ALS
Pharmaceutical Technology
JANUARY 31, 2023
Gene therapy company uniQure has entered into a global licensing agreement with Apic Bio for APB-102 to treat patients with amyotrophic lateral sclerosis (ALS) caused by mutations in superoxide dismutase 1 (SOD1). Under the terms of the deal, uniQure will obtain the worldwide rights to develop and market the clinical stage gene therapy, APB-102. uniQure stated that the license of APB-102 further strengthens its gene therapies pipeline developed for the treatment of neurological disorders as well
Vaxxinity eyes global COVID-19 vaccine market with ‘next-gen’ booster
PharmaVoice
JANUARY 31, 2023
The biotech aims to complete rolling submissions with regulators in the U.K. and Australia in the first half of 2023.
Pressure's on, GSK. Merck's Keytruda drops endometrial cancer win in first-line treatment
Fierce Pharma
FEBRUARY 3, 2023
Pressure's on, GSK.
With Livongo, did Zane Burke sell a lemon to Teladoc’s Jason Gorevic?
MedCity News
JANUARY 29, 2023
Was Livongo a good business? As Burke, now CEO of Quantum Health, touts its strength to investors ahead of a potential IPO, should the Livongo-Teladoc history give them pause?
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
US FDA approves GSK’s Jesduvroq to treat anaemia of CKD
Pharmaceutical Technology
FEBRUARY 2, 2023
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline ’s (GSK) Jesduvroq (daprodustat) to treat anaemia caused by chronic kidney disease (CKD) in adults who have been on dialysis for at least four months. Jesduvroq is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI). It is claimed to be the only HIF-PHI approved in the country that offers a new oral treatment option for adult patients on dialysis with anaemia of CKD.
Three-year patent strategy for greater medicine access announced
European Pharmaceutical Review
JANUARY 31, 2023
A new strategy for 2023-2025 by the Medicines Patent Pool (MPP) aims to reduce access inequities, by improving the availability and affordability of health products in low- and middle-income countries (LMICs). The MPP is a United Nations-backed public health organisation working to increase medicine access and facilitate the development of life-saving medicines for LMICs.
Amgen's Humira biosimilar Amjevita hits the market with two different list prices
Fierce Pharma
JANUARY 31, 2023
Amgen's Humira biosimilar Amjevita hits the market with two different list prices zbecker Tue, 01/31/2023 - 10:58
I’m a GI Doctor. A Colon Cancer Screening Could Save Your Life.
MedCity News
JANUARY 29, 2023
A recent NEJM publication concluded that although colonoscopy is widely used as a dependable screening test to detect colorectal cancer, its overall effect on the risks of colorectal cancer death is potentially less clear than previously reported. The doubt sprouting from this study is misplaced, dangerous and will potentially lead to more deaths from this disease.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Vital NICE nod for Jazz’s Epidyolex
PharmaTimes
FEBRUARY 1, 2023
UK-wide therapy for patients who have seizures linked to tuberous sclerosis complex
Clinical Trials Information System mandatory in EU
European Pharmaceutical Review
FEBRUARY 1, 2023
From 31 January 2023, all initial clinical trial applications in the European Union (EU) must be submitted via the Clinical Trials Information System (CTIS). According to the European Medicines Agency (EMA), CTIS is now the single-entry point for sponsors and regulators of clinical trials for the submission and assessment of clinical trial data. This follows a one-year transition, during which sponsors could choose whether to apply for a new clinical trial in the EU/EEA in line with the Clinical
Amid mainstream hype, Eli Lilly takes a hard line marketing its buzzy diabetes med Mounjaro
Fierce Pharma
FEBRUARY 2, 2023
Amid mainstream hype, Eli Lilly takes a hard line marketing its buzzy diabetes med Mounjaro fkansteiner Thu, 02/02/2023 - 11:20
Report: Nurse Understaffing Is Becoming More Deadly for Patients
MedCity News
FEBRUARY 2, 2023
More than 90% of nurses in Michigan believe that understaffing is negatively affecting the quality of care they’re able to provide, according to a new report. The percentage of respondents who know of a patient death being caused by nurses being assigned too many patients nearly doubled in the past seven years — from 22% in 2016 to 42% in 2023.
Pfizer reports 30% operational growth in full-year 2022 revenues
Pharmaceutical Technology
FEBRUARY 1, 2023
Pfizer has reported a 30% operational growth in revenues to $100.3bn in full-year 2022 compared with $81.2bn reported last year. The revenues grew 2% operationally excluding Paxlovid and Comirnaty’s contributions. In the fourth quarter (Q4) of 2022, they increased 13% operationally to $24.3bn compared to $23.8bn in the same quarter last year. On an operational basis, the revenues rose by 5%, omitting contributions from Paxlovid and Comirnaty.
Smart Walking Stick for Visually Impaired People
Medgadget
JANUARY 30, 2023
Researchers at the University of Colorado at Boulder have developed a smart walking stick that can assist blind or visually impaired people to navigate their environment, from grocery shopping to finding a seat in a busy café. The system employs cameras to visualize the environment and items within it, such as products in a supermarket, and uses AI to identify objects and provide guidance for the user.
Court rejects Johnson & Johnson's Texas two-step bankruptcy ploy for talc claims
Fierce Pharma
JANUARY 30, 2023
Court rejects Johnson & Johnson's Texas two-step bankruptcy ploy for talc claims kdunleavy Mon, 01/30/2023 - 16:24
Why Telehealth Implementation Is Not Just a Project for IT
MedCity News
FEBRUARY 3, 2023
Telehealth implementation should be a joint responsibility of IT, administration, and providers. Otherwise, a lack of teamwork between departments leads to siloing and lots of passing the telemedicine “hot potato” among those who don’t have all the information.
10 Ways to Leverage Buyer Signals and Drive Revenue
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
Milestone product launch for Kelso Pharma
PharmaTimes
JANUARY 30, 2023
Acepiro tablets for respiratory diseases will be available across the UK prescription market
Unpacking the Science Behind Data Integrity
PharmaTech
FEBRUARY 3, 2023
Webinar Date/Time: Thursday February 24, 2023 at 11am EST | 10am CST | 8am PST
Menarini shows Big Pharma how it's done with first approval for oral SERD drug in breast cancer
Fierce Pharma
JANUARY 30, 2023
Menarini shows Big Pharma how it's done with first approval for oral SERD drug in breast cancer kdunleavy Mon, 01/30/2023 - 10:22
Ciox, Sentara Healthcare Pilot Data Access Tool to Improve Maternal Health
MedCity News
JANUARY 30, 2023
Ciox recently partnered with Virginia-based non-profit health system Sentara Healthcare to pilot a tool that makes it easier for expectant mothers to access their health records. The fact that patients’ pregnancy data get trapped in silos is problematic because providers can use that information to predict complications and intervene sooner.
How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Let's personalize your content